Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Nuokang Bio Pharmaceutical Inc (NKBP: Nasdaq)

No earlier versions found for this Subject.

Return to Nuokang Bio Pharmaceutical Inc (NKBP: Nasdaq)

China Nuokang Bio-Pharmaceutical Inc. has an obligation to its shareholders to be honest, fair and forthright in all of its business activities; but is it possible, for its Code of Business Conduct and Ethics, advertise to be as a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products?
Because as of December 31, 2010, the Company sold a portfolio of 15 products, but of wich only one, Baquting, is the discreetly sold though under pressure of competition.